TAIPEI, 14. November 2025 /PRNewswire/ -- EirGenix Inc.(TWSE: 6589) gab am 12. November den Abschluss eines zweiten globalen Exklusivlizenzvertrags mit dem internationalen Marktführer für Biosimilars, der Sandoz AG (SIX:SDZ/OTCQX:SDZNY), für die Vermarktung seines eigenständig...
Hence then, the article about eirgenix unterzeichnete die kommerzielle lizenzvereinbarung fur sein zweites her2 biosimilar eg1206a was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( EirGenix unterzeichnete die kommerzielle Lizenzvereinbarung für sein zweites HER2-Biosimilar EG1206A )
Also on site :
- Gold Star Distribution Inc., Issues Recall of Certain FDA-Regulated Products in Three States Including Drugs, Devices, Cosmetics, Human Foods, and Pet Foods
- ’Beverly Hills, 90210’s Jason Priestley Shares Bold Callout After ‘Worst’ Travel Experience
- Central African Republic election: Who’s running and what’s at stake?